Published in Drug Week, March 10th, 2006
According to recent research from the United States, "1,1-Bis(3'-indolyl)-1-(p-substitutedphenyl)methanes containing p-trifluoromethyl (DIM-C-pPhCF(3)), p-t-butyl (DIM-C-pPhtBu), and phenyl (DIM-C-pPhC(6)H(5)) substituents have been identified as a new class of peroxisome proliferator-activated receptor gamma (PPAR gamma) agonists that exhibit antitumorigenic activity. The PPAR gamma-active C-DIMs have not previously been studied against bladder cancer."
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.